Related Experiment Videos
Challenges and opportunities in biotechnology
Progress in Clinical and Biological Research
|January 1, 1985
Summary
Biotechnology advances like gene cloning are routine, yielding initial products. Future innovations in recombinant DNA technology promise significant impacts on healthcare and pharmaceuticals.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- The biotechnology industry has seen significant advancements in the last decade.
- Gene cloning and expression are now routine procedures.
- Early commercial products have emerged, but clinical significance requires further evaluation.
Purpose of the Study:
- To outline the expected impact of biotechnology on healthcare and the pharmaceutical industry over the next decade.
- To highlight the potential of first- and second-generation recombinant DNA products.
- To identify future opportunities in drug discovery and development.
Main Methods:
- Review of current biotechnology achievements and predicted advancements.
- Analysis of the role of recombinant DNA (rDNA) technologies in product development.
- Exploration of potential new delivery systems and gene reconstruction.
Main Results:
- Recombinant vaccines, blood coagulation factors, and biological modulators are expected to see widespread use.
- New bioactive molecules and infectious agents (e.g., NANB hepatitis, AIDS) present further opportunities.
- Exploitation of healthcare products hinges on novel delivery systems and gene reconstruction.
Conclusions:
- Biotechnology is poised to substantially influence human healthcare and pharmaceuticals.
- Continued discovery and technological innovation are key to realizing full potential.
- Advanced delivery systems and gene engineering are crucial for in-situ product application.